These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21712333)

  • 1. High prevalence of HIV and hepatitis B and C is found among injecting drug users.
    Zarocostas J
    BMJ; 2011 Jun; 342():d4078. PubMed ID: 21712333
    [No Abstract]   [Full Text] [Related]  

  • 2. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Ann Ist Super Sanita; 2010; 46(1):59-65. PubMed ID: 20348620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Scand J Infect Dis; 2009; 41(6-7):520-3. PubMed ID: 19415569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India.
    Saha MK; Chakrabarti S; Panda S; Naik TN; Manna B; Chatterjee A; Detels R; Bhattacharya SK
    Indian J Med Res; 2000 Feb; 111():37-9. PubMed ID: 10824464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D virus and other chronic viral infections in high risk populations: interaction from an epidemiologic perspective.
    Stevens CE
    Prog Clin Biol Res; 1991; 364():361-4. PubMed ID: 1902297
    [No Abstract]   [Full Text] [Related]  

  • 8. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002.
    Davoodian P; Dadvand H; Mahoori K; Amoozandeh A; Salavati A
    Braz J Infect Dis; 2009 Oct; 13(5):356-8. PubMed ID: 20428635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
    Kolovrat A; Jurisić I; Marić Z; Cvitković A
    Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early decline in an epidemic: evolution of the prevalences of HIV, hepatitis B, hepatitis C and aminotransferases in intravenous drug abusers in Strasbourg between 1980 and 1990].
    Will T
    Rev Med Suisse Romande; 1999 Apr; 119(4):329-34. PubMed ID: 10361471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z; Gorisek JR; Poljak M; Pisec A
    Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.